WITH troubles at Corning/Quest and LabCorp attracting publicity during the previous 18 months, few people observed a discreet but important change at SmithKline Beecham Clinical Laboratories (SBCL).
John B. Okkerse, Jr., Ph.D. has quietly assumed full executive responsibility
at the $1 billion company. Although Okkerse was promoted to President in 1995, Vickery Stoughton was the Chief Executive
Subscriber-Only Content. Please Log In.
You are trying to access subscribers-only content. If you are a subscriber, please log in.
If you are not a subscriber, click here to see subscription offers.
Subscribers will have instant access to the Dark Report library, 1997-the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!
To read our FREE article previews, go to The Dark Report Insider.